Cargando…

Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience

Detalles Bibliográficos
Autores principales:	Rose, Tracy L., Weir, William H., Mayhew, Gregory M., Shibata, Yoichiro, Eulitt, Patrick, Uronis, Joshua M., Zhou, Mi, Nielsen, Matthew, Smith, Angela B., Woods, Michael, Hayward, Michele C., Salazar, Ashley H., Milowsky, Matthew I., Wobker, Sara E., McGinty, Katrina, Millburn, Michael V., Eisner, Joel R., Kim, William Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023585/ https://www.ncbi.nlm.nih.gov/pubmed/35277660 http://dx.doi.org/10.1038/s41416-022-01781-y

Ejemplares similares

Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer
por: Eisner, Joel R., et al.
Publicado: (2022)

Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer
por: Damrauer, Jeffrey S., et al.
Publicado: (2022)

Cesarean scar ectopic pregnancy: Case report(☆)()
por: Brancazio, Sophia, et al.
Publicado: (2019)

Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study
por: Eisner, Joel R., et al.
Publicado: (2023)

Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy
por: Rose, Tracy L., et al.
Publicado: (2018)

Large Cell Change in a Small Liver: A Histological Clue to Short Telomere Syndromes?
por: Johnson, Steven M., et al.
Publicado: (2020)

Immune checkpoint inhibitors for urothelial carcinoma
por: Kim, Hyung Suk, et al.
Publicado: (2018)

Anastomosing hemangioma of the liver: An unusual variant in abdominal MRI imaging
por: Rogers, Tyler, et al.
Publicado: (2022)

Easy solos for beginning flutists
por: McGinty, Anne
Publicado: (1977)

#DitchtheDisk
por: McGinty, Geraldine
Publicado: (2022)

Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor
por: Chiang, Ryan S., et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in the Management of Urothelial Carcinoma
por: Patel, Aakash, et al.
Publicado: (2021)

Overt Attention toward Appetitive Cues Enhances Their Subjective Value, Independent of Orbitofrontal Cortex Activity
por: McGinty, Vincent B.
Publicado: (2019)

BDNF as a therapeutic candidate for cocaine use disorders
por: McGinty, Jacqueline F.
Publicado: (2022)

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma
por: Abida, Wassim, et al.
Publicado: (2016)

The Evolution of Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
por: Houssiau, Hélène, et al.
Publicado: (2022)

Immunotherapy With Checkpoint Inhibitors in FGFR-Altered Urothelial Carcinoma
por: Benjamin, David J, et al.
Publicado: (2022)

Gallbladder agenesis mimicking cholelithiasis in an adult
por: Moon, Andrew M., et al.
Publicado: (2018)

Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer
por: Abuhelwa, Ahmad Y., et al.
Publicado: (2021)

Mesenchymal gene expression subtyping analysis for early-stage human papillomavirus-negative head and neck squamous cell carcinoma reveals prognostic and predictive applications
por: Mayhew, Gregory M., et al.
Publicado: (2022)

Nucleosome Structure and Function
por: McGinty, Robert K., et al.
Publicado: (2014)

Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
por: Chen, Siteng, et al.
Publicado: (2020)

Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma
por: Tsai, Chung-Ying, et al.
Publicado: (2021)

Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer
por: Parent, Pauline, et al.
Publicado: (2023)

Patient Cost-Sharing and Utilization of Breast Cancer Diagnostic Imaging by Patients Undergoing Subsequent Testing After a Screening Mammogram
por: Hughes, Danny R., et al.
Publicado: (2023)

Dynamics of Whale Shark Occurrence at Their Fringe Oceanic Habitat
por: Afonso, Pedro, et al.
Publicado: (2014)

Heterogeneity in the Paraventricular Thalamus: The Traffic Light of Motivated Behaviors
por: McGinty, Jacqueline F., et al.
Publicado: (2020)

Adapting to Succeed in Radiology’s Postpandemic Future
por: McGinty, Geraldine B., et al.
Publicado: (2020)

Monkeys exhibit human-like gaze biases in economic decisions
por: Lupkin, Shira M, et al.
Publicado: (2023)

A bipartite graph-based expected networks approach identifies DDR genes not associated with TMB yet predictive of immune checkpoint blockade response
por: Weir, William H., et al.
Publicado: (2022)

Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the Literature
por: Cockrell, Dillon C., et al.
Publicado: (2020)

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
por: Gopalakrishnan, Dharmesh, et al.
Publicado: (2018)

Immune checkpoint inhibitors as a real hope in advanced urothelial carcinoma
por: Seront, Emmanuel, et al.
Publicado: (2018)

Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma
por: Aicher, Wilhelm K., et al.
Publicado: (2021)

Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
por: Wang, Di, et al.
Publicado: (2021)

Cost-Effectiveness of Immune Checkpoint Inhibitors in Urothelial Carcinoma—A Review
por: Walia, Arman S., et al.
Publicado: (2021)

Looking Beyond Th17 Cells: A Role for Tr1 Cells in Ankylosing Spondylitis?
por: McGinty, Joanna, et al.
Publicado: (2020)

How Does Fluid Flow Influence Drug Release from Drug Filled Implants?
por: King, David, et al.
Publicado: (2022)

New and Emerging Therapies in the Management of Bladder Cancer
por: Osterman, Chelsea K., et al.
Publicado: (2020)

Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7aa3ojsb78n0mik25cqvrrb94v